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Megalin (LRP-2/GP330), a member of the LDL receptor family, is an endocytic receptor expressed mainly in polarised epithelial cells.
Identified as the pathogenic autoantigen of Heymann nephritis in rats, its functions have been studied in greatest detail in adult mammalian kidney,
but there is increasing recognition of its involvement in embryonic development. The megalin homologue LRP-1 is essential for growth and
development in Caenorhabditis elegans and megalin plays a role in CNS development in zebrafish. There is now also evidence for a homologue
in Drosophila. However, most research concerns mammalian embryogenesis; it is widely accepted to be important during forebrain development
and the developing renal proximal tubule. Megalin is also expressed in lung, eye, intestine, uterus, oviduct, and male reproductive tract. It is found
in yolk sacs and the outer cells of pre-implantation mouse embryos, where interactions with cubilin result in nutrient endocytosis, and it may be
important during implantation. Models for megalin interaction(s) with Sonic Hedgehog (Shh) have been proposed. The importance of Shh
signalling during embryogenesis is well established; how and when megalin interacts with Shh is becoming a pertinent question in developmental
biology.
© 2006 Elsevier Inc. All rights reserved.Keywords: Megalin; Development; Sonic hedgehog; RAP; LDLR; Cholesterol; Endocytosis; HSPGs; Cubilin; Expression patternsIntroduction
The low-density lipoprotein (LDL) receptor gene family
originated early in metazoan evolution (May and Herz, 2003).
To date, proteins in this family have only been identified in
multicellular organisms; genome analysis has revealed no
homologues in unicellular eukaryotes, suggesting no role in
the division and survival of these organisms (Herz and Bock,
2002). The mammalian LDL receptor family consists of seven
core members (LDLR, VLDLR, ApoER2, MEGF7, LRP,
LRP-1b, and megalin) and three distantly related receptors
(LRP-5, LRP-6, and LR11/SorLA). Ligands have been
identified for each of the family members; for review see
Hussain et al. (1999). Orthologues of some members, almost
identical in structure to their mammalian counterparts, have
been identified in Caenorhabditis elegans and Drosophila
melanogaster (Herz and Bock, 2002). The Drosophila gene⁎ Corresponding author. Fax: +33 131 242 9199.
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doi:10.1016/j.ydbio.2006.06.007CG12139 was identified as a megalin homologue in March
2006 (http://www.genecards.org).
LDL receptors are endocytic transmembrane glycoproteins
characterised by a large extracellular domain, comparatively
short intracellular domains (Hussain et al., 1999), and, for core
members, a single membrane-spanning domain that anchors the
protein to the plasma membrane (May and Herz, 2003). The
cytoplasmic tail contains one or more NPxY motifs that act as
docking sites for adaptor proteins containing phosphotyrosine-
binding (PTB) domains and as signals for endocytosis. Core
members are also characterised by the presence of cysteine-rich
repeats of both ligand binding and EGF types and YWTD
domains that form folds of β-pleated sheets (Herz and Bock,
2002). The more distantly related receptors share some but not
all of the defining structural features of the core members of the
family, along with additional structural or functional domains.
For example, LRP-5 and LRP-6 do not contain the intracellular
NpxY motif shared by the core members but have five copies of
PPP(S/T)P motifs instead (He et al., 2004).
The work of Brown and Goldstein (1979) was ground
breaking in terms of understanding receptor-mediated endocytosis,
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for internalisation and intracellular processing. This work led
to the establishment of a model for receptor-mediated endo-
cytosis that has been applied successfully to more recently
discovered LDLRs with specificities for different kinds of
lipoproteins. As well as functioning in the cellular uptake of
extracellular ligands, LDLRs regulate various other biological
processes including lipid and vitaminmetabolism. Some have a
role in cellular signalling and others function during embry-
ogenesis, and it has been established that all members of the
LDLR family are present in the CNS.
Reviewing the structure and function of each of the LDLR
family members is beyond the scope of this article. The
mammalian LDLR family has been the subject of a compre-
hensive review (Hussain et al., 1999) and more specialised
reviews concerning the role(s) of LDLRs in the CNS are
available (Herz, 2001; Herz and Bock, 2002; May and Herz,
2003). This article will focus on one member of the family,
megalin, emphasising its roles during homeostasis and devel-
opment, and also its interactions with the developmental
morphogen sonic hedgehog (Shh). The interactions between
Shh and megalin will be examined and a brief outline of the Shh
pathway will be presented; readers unfamiliar with the Shh
signalling pathway are directed to the review by Cohen (2003).
Megalin, associated molecules and endocytosis
Like all members of the LDLR family, megalin is an
endocytic transmembrane glycoprotein. It does not require
associated molecules for endocytosis and degradation of ligands
but binding to such ligands may be facilitated by proteoglycans
(Marino et al., 2001). Receptor-associated protein (RAP), which
is co-expressed with megalin in many developing tissues, has
been utilised to study megalin–ligand trafficking and is
involved in the biosynthesis of members of the LDL receptor
gene family. The membrane receptor cubilin has many ligands
in common with megalin. Although cubilin has no transmem-
brane domain and is therefore reliant on megalin for endocytosis
of certain ligands (CC10 in kidney, for example) and both
receptors interact during peri-implantation, interactions with
cubilin are not necessary for megalin function.
Megalin
Megalin (gp330/LRP-2) was initially identified as the
pathogenic autoantigen of Heymann nephritis (Kerjaschki and
Farquhar, 1982). By 1996, the gene had been sequenced in rat
and humans (Saito et al., 1994; Hjälm et al., 1996) and mapped
to chromosome 2 (Xia et al., 1993). It is a 600-kDa integral
membrane protein found in many absorptive epithelia (Ray-
chowdhury et al., 1989) and is both structurally and functionally
related to low-density lipoprotein receptor-related protein
(LRP), another core member of the LDLR family. Both proteins
are of similar size, bind many of the same ligands (Willnow et
al., 1992; reviewed in Hussain et al., 1999), and are co-
expressed in many epithelia during development (Kounnas et
al., 1994). Megalin contains a single transmembrane domain(Xia et al., 1993), is known to act as an endocytic receptor and is
expressed primarily on the apical surfaces of polarised epithelial
cells (Kounnas et al., 1994). The extracellular region contains
17 EGF-like, 36 LDLR type A and 37 LDLR type B domains
and YWTD domains (Springer, 1998). The cytoplasmic (C-
terminal) region contains three NPxY motifs; residues 107–
136, which include the second motif, are critical for apical
sorting and targeting, whereas the regions containing the first
and third NpxY motifs are needed for efficient endocytosis and
signalling activities (Takeda et al., 2003). The extracellular
YWTD domains are important in the pH-dependent dissociation
of ligand complexes (Davis et al., 1987). A schematic
representation of megalin protein and its binding domains is
shown in Fig. 1A.
Expression of megalin has been reported in a wide variety
of adult tissues including mammary epithelia, thyroid
follicular cells and the ciliary body of the eye (Lundgren et
al., 1997). It is found in the intestinal brush border (Yammani
et al., 2001), the male reproductive tract (Van Praet et al.,
2003), uterus and oviduct (Argraves and Morales, 2004),
gallbladder epithelium (Erranz et al., 2004), type II pneumo-
cytes (Chatelet et al., 1986; Lundgren et al., 1997) and kidney.
It is also expressed in yolk sacs (Lundgren et al., 1997). Data
from megalin-deficient mice imply developmental roles in the
kidney along with lung and CNS (Willnow et al., 1996). The
roles and functions of megalin during embryogenesis, and
specifically organogenesis, will form the basis of the following
section of this review.
Cubilin
The 460-kDa receptor protein cubilin (gp280) is a peripheral
protein that complexes with megalin and is required for
megalin-dependent endocytosis of many ligands in kidney
tubules and other epithelia (Birn et al., 2000a; Hammad et al.,
2000; Barth and Argraves, 2001; Moestrup and Verroust, 2001;
Nykjaer et al., 2001; Christensen et al., 2003). For example, in
the kidney CC10 binds to cubilin before undergoing megalin-
dependent internalisation and degradation (Burmeister et al.,
2001). Cubilin mediates the endocytosis of gastric intrinsic
factor–cobalamin (vitamin B12) complexes from the distal small
intestine (Xu et al., 1999), as does the functionally related
protein amnionless (AMN) (Strope et al., 2004), a 48-kDa
apical membrane protein. Cubilin and AMN are subunits of a
receptor complex called cubam (Fyfe et al., 2004); AMN is
required for its membrane attachment and export from the
endoplasmic reticulum, and extracellular cubilin is involved in
apical sorting of the complex (Coudroy et al., 2005). AMN is
also responsible for cubilin brush-border expression (He et al.,
2005).
Cubilin lacks a membrane-spanning domain (Moestrup et
al., 1998) and is attached to the extracellular surfaces of
epithelial cells by its 110-residue N-terminal sequence (Bork
and Beckmann, 1993). This N-terminal region contains a
number of EGF-like, bone morphogenic protein (BMP)-like and
complement (C1r/C1s)-like repeats (Kristiansen et al., 1999).
Although the distribution of cubilin is more restricted than that
Fig. 1. Binding domains of megalin and RAP. (A) Schematic representation of megalin protein, highlighting the binding site for RAP (amino acids 1111–1210) within
the second cluster of ligand-binding repeats. (B) Ligand-binding map of RAP, showing the two megalin-binding sites (between amino acids 85–148 and 178–248) and
the binding site for heparin (amino acids 261–323). This figure was adapted from Orlando and Farquhar (1994), Saito et al. (1994), Orlando et al. (1997), and Herz
(2001).
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both neonatal and adult mice the cubilin gene is transcribed in
tissues that also express megalin (Hammad et al., 2000). This
led to the proposal that it functions in endocytosis only as a
complex with megalin. However, a study by Moestrup's group
(Fyfe et al., 2004) utilising transfected cells in which megalin
could not be detected demonstrated that the cubam receptor
(mentioned above) can function independently of megalin and
that AMN is responsible for the endocytosis of cubilin–ligand
complexes (Fyfe et al., 2004). The authors do not exclude the
possibility that megalin can/does interact with the cubilin/AMN
complex and a functional relationship between cubilin, AMNand megalin has been suggested by Strope et al. (2004).
However, it may be misleading to suggest an absolute
requirement for megalin during cubilin–ligand endocytosis.
Receptor-associated protein (RAP)
Receptor-associated protein (RAP) is so-called because it co-
purifies with both megalin (Kounnas et al., 1992; Orlando et al.,
1992) and LRP (Strickland et al., 1990). In humans and mice, it
is a 39-kDa protein (Kounnas et al., 1994); the rat homologue
has a molecular mass of 44 kDa (Orlando et al., 1992). RAP is
co-expressed with both LRP and megalin in various tissues
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RAP was shown to bind megalin, and it was proposed to assist
in biosynthetic processing and/or trafficking of this receptor
(Kounnas et al., 1992). RAP modulates ligand binding by
members of the LDLR family (Battey et al., 1994), promotes the
folding, trafficking and maturation of LDL (Li et al., 2002) and
is crucial for the normal processing and function of megalin
(Birn et al., 2000b). The proposed functions of RAP have led,
rightly or wrongly, to it being referred to as a specialised
molecular chaperone and/or escort protein (Bu et al., 1995;
Willnow, 1998; Willnow et al., 1995; Birn et al., 2000b; Li et
al., 2002). Irrespective of nomenclature, it is clear that RAP has
important roles during biosynthesis of LDLR family members
and endocytosis of megalin–ligand complexes (as discussed
below). It binds to megalin with high affinity (Kd = 8 nM)
(Kounnas et al., 1992) and this binding is calcium dependent
(Christensen et al., 1992; Biemesderfer et al., 1993). Two
primary megalin-binding sites have been identified, between
residues 85 and 148 and between residues 178 and 248
(Orlando and Farquhar, 1994; see Fig. 1B).
It has been shown that residues 1111–1210 in megalin
encompass a binding site for various ligands including RAP
(Orlando et al., 1997). Although the authors of this study
concluded that megalin contained one binding site that is
common to several ligands, a more recent report suggests that
megalin contains more than a single RAP-binding site
(McCarthy et al., 2002). The most closely related member of
the LDLR family, LRP, has multiple RAP-binding sites
(Williams et al., 1992), so it is reasonable to suppose that the
same applies to megalin. However, the details of megalin–RAP
binding interactions remain elusive (Kounnas et al., 1992),
although it is clear that accessory molecules such as
proteoglycans can play a role.
Heparan sulphate proteoglycans (HSPGs)
Heparan sulphate proteoglycans (HSPGs) have been impli-
cated in megalin function (McCarthy et al., 2002); however,
megalin does not specifically bind heparin (Orlando and
Farquhar, 1993) and the interaction is indirect. In the thyroid
gland, HSPGs are involved in megalin binding to thyroglobulin
(Tg). Marinò et al. (1999a) identified a 15 amino acid sequence
between Arg689 and Lys703 in the carboxyl-terminal region of
rat Tg that constitutes a heparin-binding region involved in
megalin binding. HSPGs have been shown to bind to this
heparin-binding sequence on Tg, facilitating binding of the
prohormone to megalin and ultimately its transcytosis (Lisi et
al., 2003). These studies demonstrate the importance of HSPGs
for megalin to bind certain ligands.
In vitro studies demonstrate that RAP can bind directly to
heparin; the heparin-binding site is between residues 261 and
323 (Orlando and Farquhar, 1994). The megalin- and heparin-
binding sites in RAP are non-contiguous, implying that the
glycosaminoglycan site may be physiologically exposed when
RAP is bound to megalin (Orlando and Farquhar, 1994). This
means that megalin requires heparin-binding ligands in order
to interact with HSPGs for signalling and/or endocytosis.Therefore, HSPGs may interact with megalin in different
ways depending on the tissue and ligand(s) involved.
Mechanisms of megalin action: endocytosis and signalling
After the initial discovery in the early 1980s that circulating
autoantibodies bind to megalin causing Heymann nephritis,
much research focused on the role of megalin in the renal system.
Antibody–megalin complexes result in immune deposits in the
glomerular basement membrane, which in turn lead to damage in
the glomerular capillary wall and inevitably proteinuria (as
reviewed by Kerjaschki and Neale, 1996; Christensen et al.,
1998). Numerous studies including analysis of megalin-
deficient mice and dogs with a functional defect in cubilin
demonstrate that both proteins are key receptors in the
endocytosis of various ligands in the kidney proximal tubule
(Leheste et al., 1999; Birn et al., 2000a). They interact during
early embryogenesis to provide nutrition to the developing
embryo, although cubilin is not the only co-receptor involved in
megalin function and endocytosis, and it is not essential for
megalin to function.
Because megalin was originally recognised as an important
mediator of kidney proximal tubule function, research has
focused predominantly on its role in endocytosis. Megalin and
its orthologues are proposed to endocytose dietary sterols such
as cholesterol, and this function is not only important in many
adult tissues but also during embryogenesis. Megalin is required
in order that cholesterol can be taken up by the visceral yolk sac
in early post-implantation mammalian blastocysts (Assémat et
al., 2005a) and the neuroepithelium before neural tube closure
(Willnow et al., 1996); in C. elegans, the orthologue of megalin
is also thought to be essential for sterol uptake and therefore
normal development (Yochem et al., 1999).
However, the interactions between megalin and scaffold
proteins, which are usually mediated through cytosolic
adaptors, imply a diversity of other functions in cellular
communication and signal transduction (Gotthardt et al.,
2000). Interactions involving megalin's cytoplasmic (C-term-
inal) moiety are responsible for its polarised distribution in
epithelial cells (Marzolo et al., 2003), and several adaptor
molecules that bind this moiety to various intracellular proteins
have been identified. These include proteins with PTB and PDZ
domains and proteins with ankyrin and tetratrico repeat
elements (Gotthardt et al., 2000; Petersen et al., 2003; Rader
et al., 2000). Another potential intracellular adaptor molecule,
megalin-binding protein (MegBP), has been identified by
Petersen and co-workers (2003). The binding site for MegBP
was mapped to a proline-rich element of the N-terminal region
of the megalin tail, and it is thought to bind megalin to a range of
intracellular proteins. Proteins linked to megalin via MegBP
include transcriptional regulators such as the SKI-interacting
protein (SKIP), a co-activator of the vitamin D receptor
(Petersen et al., 2003). The discovery that MegBP links SKIP
to megalin suggests that megalin might participate in the
regulation of transcription, and the recent observation that
megalin can undergo proteolysis in situ in the membrane might
suggest a role in cell signalling (Zou et al., 2004). In support of
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guanylate kinase family, PSD-95 (Larsson et al., 2003).
The adaptor protein disabled-2 attaches to FxNPxY
sequences in the megalin tail (Gallagher et al., 2004), as
does autosomal recessive hypercholesterolemia (ARH). ARH
is a PTB protein (Garcia et al., 2001); it binds to the first of
the two FxNPxY motifs (Nagai et al., 2003). It is first seen in
association with internalised megalin in clathrin-coated pits,
then in early endosomes, followed by recycling endosomes
and finally at the cell surface again (Nagai et al., 2003). ARH
appears to facilitate megalin-related endocytosis and possibly
acts as a chaperone during the process.
Studies in which cells are given exogenous RAP have been
utilised to study megalin–ligand trafficking and the distribution
of both RAP and megalin during endocytosis. They do not refer
to endogenous RAP, which is not secreted extracellularly. They
reveal that although trafficking through early endosomes is
characteristic of ligand-bound megalin, in the absence of ligands
this process involves RAP (Bu et al., 1995; Willnow et al.,
1995). Like ARH, RAP appears to be necessary during
endocytosis for normal processing and subcellular distribution
of megalin. It has been demonstrated to bind to megalin shortly
after its synthesis in the rough endoplasmic reticulum (Biemes-
derfer et al., 1993). During endocytosis, megalin–RAP com-
plexes appear to cycle through late endosomes. From these,
megalin is returned to the cell surface whereas RAP undergoes
lysosomal degradation (Czekay et al., 1997). Levels of megalin
in kidney proximal tubule cells fall significantly in the absence
of RAP. Concomitantly, its distribution changes; less is detected
on the brush-border membrane and relatively more is found on
the rough endoplasmic reticulum (Birn et al., 2000b).
Megalin and homeostasis
Megalin is detected on embryonic structures that give rise to
homeostatic organs such as the thyroid, parathyroid (Assémat et
al., 2005b) and kidney (Sahali et al., 1993; Assémat et al.,
2005b). With the exception of the metanephros, there is little
information concerning the expression and/or function(s) of
megalin during the development of organs primarily involved
with body homeostasis. However, as outlined below, it is clear
that megalin is important in controlling body homeostasis in
adult mammals. This implies that proper expression and
function of megalin during development of these organs may
be prerequisites for normal maturation and survival.
Thyroid
A negative-feedback pathway involving thyroid stimulating
hormone (TSH) prevents over- and under-secretion of the
thyroid hormones. The functional unit of the thyroid, the
follicle, is composed of a layer of thyrocytes (epithelial cells)
surrounding a lumen containing colloid, of which a major
constituent is the prohormone thyroglobulin (Tg). Tg is
synthesised and then released into the lumen of the follicle by
thyrocytes (Ericson, 1981). The release of thyroid hormones
requires the iodination of tyrosyl residues on Tg (Taurog et al.,1996), its uptake by thyrocytes and transportation to lysosomes,
where proteolytic cleavage results in hormone release (as
reviewed by Dunn et al., 1992). Megalin has a key role in
thyroid hormone secretion and therefore in the control of body
homeostasis.
Megalin is expressed in a TSH-dependent manner on the
apical surface of thyrocytes, binds to Tg with high affinity and
mediates its endocytosis (Marinò et al., 1999b, 2000); the role
of HSPGs in this process was mentioned earlier. Most Tg
endocytosed by this mechanism is low hormonogenic; it
undergoes apical–basolateral transcytosis and is released into
the blood stream (Marinò et al., 2000; Lisi et al., 2003). This is
thought to divert low-hormonogenic Tg from the lysosomes,
allowing mainly high-hormonogenic Tg to undergo proteolytic
cleavage and consequent release of hormones, thereby favour-
ing more effective hormone secretion (Lisi et al., 2003). Cell
culture studies incorporating megalin blocking experiments and
immunoprecipitation data suggest that lack of functional
megalin on thyrocytes impairs the transcytosis of low-hormone
Tg, which therefore competes with high-hormonogenic Tg for
the lysosomal pathway; this should result in hypothyroidism
(Lisi et al., 2003). Ninety-eight percent of megalin−/− mice die
perinatally (Willnow et al., 1996), but for unknown reasons
some do survive to adulthood. A study comparing adult mice
heterozygous for the disrupted megalin gene with megalin−/−
mice revealed hypothyroidism in the KO animals, accompanied
by low serum levels of Tg and high levels of TSH (Lisi et al.,
2005).
Kidney and parathyroid
The functions of megalin have been studied in greatest detail
in the renal proximal tubule, where it is associated with the
sodium-potassium exchanger (Biemesderfer et al., 1999). It is
necessary for the reabsorption of retinol (Christensen et al.,
1999), vitamin D (Hilpert et al., 2002), vitamin B12 (Birn et al.,
2002) and calcium (Frick and Bushinsky, 2003) and for
angiotensin II uptake (Gonzalez-Villalobos et al., 2004).
Megalin is strongly expressed in proximal tubule (PT) cells in
adult rodent kidneys (Birn et al., 2000b; Biemesderfer et al.,
1992), primarily in coated pits along the apical domain
(Biemesderfer et al., 1992) and in microvilli of the brush
border (Kerjaschki and Farquhar, 1983; Christensen et al.,
1995). It is also expressed in endocytic vesicles, membrane
recycling compartment dense apical tubules (DAT) and some
lysosomes (Christensen et al., 1995). Megalin is expressed at
low levels in glomerular podocytes of Lewis rats (Assémat et
al., 2005b). No other rat strain or species, including humans
(Ronco and Debiec, 2005), has been shown to express megalin
in these cells.
Vitamin A (VA) derived metabolites (retinoids) increase
embryonic viability and positively impact embryonic develop-
ment (Eberhardt et al., 1999). Plasma retinol (ROH) is
transported by retinol-binding protein (RBP). Although the
liver is the main site of RBP synthesis, and hepatic VA storage
and mobilisation are important for homeostatic regulation of
retinol, approximately 50% of the circulating ROH pool
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demonstrated a crucial role for megalin in VA homeostasis and a
further study in 2005 utilising mice with a kidney-specific
defect in megalin gave insight as to the intrinsic nature of that
role. The latter study demonstrated that megalin is essential for
ROH homeostasis by virtue of its role in ROH-RBP reabsorp-
tion in kidney PT, and also that kidney-specific megalin
inactivation affects hepatic VA storage; rapid hepatic VA
mobilisation ensues, probably in response to uncontrolled
urinary ROH excretion (Raila et al., 2005). Although many
questions remain regarding regulation of VA metabolism,
megalin has a crucial homeostatic role.
There is significant functional interplay between kidney and
parathyroid gland in respect of calcium, phosphate, vitamin D
and parathyroid hormone (PTH) metabolism. Within minutes of
reduction in extracellular [Ca2+], PTH, produced and secreted
by parathyroid chief cells, is released into the circulation. It
mobilises calcium by osteoclastic breakdown of bone, increases
renal reabsorption and stimulates renal conversion of 25-OH
vitamin D3 to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], which
in turn increases intestinal absorption of dietary calcium
(Hilpert et al., 1999).
The unique ability of the parathyroid gland to respond to
changes in extracellular [Ca2+] is due to Ca2+-sensing
molecules on parathyroid cell surfaces, thought to be involved
in regulating cytoplasmic [Ca2+] and PTH release (Nemeth and
Scarpa, 1987). One such Ca2+-sensing molecule, later identified
as megalin, was discovered by Juhlin and co-workers (1987,
1988, 1990). It contains Ca2+binding sites on its extracellular
domain (Christensen et al., 1992; Lundgren et al., 1994) and is
found in several rat cell types with presumed or demonstrated
Ca2+-sensing ability; many of these also express parathyroid
hormone-related protein (PTHrP) (Lundgren et al., 1997).
Antibodies binding to megalin inhibit the effect of increased
external [Ca2+] on PTH secretion (Juhlin et al., 1987).
PTH is predominantly cleared from the circulation by
glomerular filtration. Renal PTH catabolism is impaired in
megalin KO mice, resulting in a 4-fold increase in levels of
amino-terminal PTH fragments in urine compared to wild-type
litter mates (Hilpert et al., 1999). However, the total amount and
subcellular localisation of PTH/PTHrP receptor in kidney PT
cells is unaffected (Hilpert et al., 1999). RAP-deficient mice
have decreased renal megalin expression and disturbed
endocytosis in the PT (Birn et al., 2000b). It is thought that
lysosomal degradation of PTH is mediated through a RAP-
sensitive receptor (Hilpert et al., 1999), and RAP-deficient mice
have impaired PTH-induced endocytosis (Bacic et al., 2003). It
is unclear whether reduced megalin levels are solely responsible
for this or if other factors are also affected by RAP deficiency,
but PTH receptor expression in kidney PT cells is not affected in
RAP KO mice (Bacic et al., 2003).
Dietary inorganic phosphate (Pi) intake and PTH regulate Pi,
which is reabsorbed in the renal PT via Na+/Pi cotransporter
type IIa (NaPi-IIa). Megalin is involved in regulating NaPi-IIa,
and PTH-induced internalisation of NaPi-IIa in kidney is
delayed in RAP-deficient mice although its distribution and
abundance remain unaltered (Bacic et al., 2003). Residualmegalin expression may be sufficient for endocytosis, or other
proteins may partially compensate for RAP. Alternatively, RAP
might alter the expression or function of other proteins
important for NaPi-IIa function/retrieval (Bacic et al., 2003).
Circulating levels of 1,25(OH)2D3 depend mainly on the
renal cytochrome P450 enzyme 25-hydroxyvitamin D3-α-
hydroxylase (1α-hydroxylase), which is potentially induced
by PTH. The function of 1α-hydroxylase is not fully defined but
activity/expression is seen in extra-renal sites expressing
megalin, where local synthesis of 1,25(OH)2D3 appears to
fulfil autocrine or paracrine functions (Hewison et al., 2000).
Parathyroid gland chief cells express 1α-hydroxylase mRNA
and protein (Segersten et al., 2002). Megalin is also expressed in
these cells (Lundgren et al., 1997), consistent with its putative
capacity for local synthesis of 1,25(OH)2D3, which contributes
to feedback regulation of parathyroid function by suppressing
PTH gene transcription and inhibiting PTH secretion and cell
proliferation (Hellman et al., 1999; Silver et al., 1999).
Decreased renal 1,25(OH)2D3 production and high phos-
phate levels may be principal causes of parathyroid glandular
enlargement in hyperparathyroidism (Slatopolsky et al., 1999).
Although work concerning the role(s) of 1α-hydroxylase, PTH
and Ca2+-sensing receptors in hyperparathyroidism (HPT) and
adenomas has been carried out in the last decade (Lundgren et
al., 1997; Farnebo et al., 1998; Knutson et al., 2000; Segersten
et al., 2002), no clear correlation between the levels of these
various molecules and disease severity has been elucidated.
Megalin and development
Work concerning the expression and possible functions of
megalin has centred on the renal system, owing to its discovery
as the Heymann nephritis autoantigen, and on the CNS, because
of the phenotypic characteristics of megalin−/−mice. However,
there is a growing body of evidence for megalin functions in the
male and female reproductive tracts and the thyroid gland, and it
is known to be expressed in several other organs, even though
definitive functions have not been investigated. This section
outlines what is known about the role of megalin in thyroid, the
reproductive system, and the developing CNS and renal system
and identifies other organs in which it is expressed. Current
knowledge of megalin function in the nematode C. elegans and
zebrafish is reviewed briefly before the expression and possible
functions of the protein during mammalian organogenesis are
discussed.
C. elegans
The nematode C. elegans comprises approximately 1000
cells. Several genes in this organism share conserved domains
with members of the mammalian LDLR family, notably those
encoding LRP-1 and LRP-1b. These high molecular mass
proteins were originally named to reflect their close structural
similarities with mammalian LRP (Yochem and Greenwald,
1993), but subsequent studies have shown that LRP-1 is more
closely related to megalin (Saito et al., 1994). The role of LRP-
1b in C. elegans remains unclear (Herz and Bock, 2002), but
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growth and development. Mutations prevent shedding and
degradation of old cuticle during larval moults and usually
cause growth arrest at the moult between the third and fourth
larval stages (Yochem et al., 1999). These effects impair the
larva's ability to feed (Herz and Bock, 2002).
The components of the cuticle, a collagen-rich exoskeleton
and environmental barrier, are secreted from the hyp7 syncytium.
This structure makes up most of the epidermis (hypodermis) of
C. elegans larva; its apical plasma membrane is the outermost
membrane for most of the body length and LRP-1 is present on
the apical surface. LRP-1 might regulate extracellular proteases;
thus, the inability of mutant larvae to degrade the cuticle could be
the result of inadequate proteolysis of the exoskeleton (Yochem
et al., 1999). The proposal is based on two observations. First, the
extracellular moiety of LRP-1 must be close to or in contact with
the overlying cuticle if shedding is to occur. Second, the
mammalian homologue of LRP-1, megalin, is believed to
regulate extracellular proteases; this may partly account for its
role in cholesterol metabolism and lung abnormalities found in
null mice (see below) (Willnow et al., 1996).
The phenotypic effect of sterol starvation in C. elegans and
other nematodes, incomplete moults, is indistinguishable from
that of LRP-1mutation (Bottjer et al., 1984;Coggins et al., 1985).
This observation has led to an alternative proposal. Megalin
endocytoses dietary sterols such as cholesterol from extracellular
fluids that are in contact with polarised epithelia. LRP-1 is also
endocytic, as evidenced by the presence of large multivesicular
bodies in the syncytial epidermis (Yochem et al., 1999). Because
nematodes absorb sterols mainly through the epidermis rather
than the intestine (Fleming and Fetterer, 1984) and LRP-1 is
present on the apical surface of hyp7 syncytium, it is suggested
that LRP-1, like megalin, is required for sterol uptake.
This proposal remains speculative because it is not clear why
sterols are essential for nematodes (Chitwood, 1992). However,
Ce-imp-2, a critical regulator of development, potentially
interacts with lipid-lipoprotein receptor-mediated pathways
(Grigorenko et al., 2004). Knockdown of Ce-imp-2 leads to
embryonic death and an abnormal moulting phenotype in C.
elegans (Grigorenko et al., 2004); this protein is required for
proper development and complete shedding of old cuticle in all
four larval moults. Loss of function in several other genes
including daf-9 and let-512, which are involved in lipid and
steroid homeostasis or signalling, results in abnormalities that
include moulting defects (Jia et al., 2002; Roggo et al., 2002).
The loss of Ce-imp-2 function was mimicked by cholesterol
depletion and partly suppressed by expression of a Ce-lrp-1
derivative; Grigorenko et al. (2004) conclude that Ce-imp-2
may promote trafficking of Ce-lrp-1 to the cell surface. The
cholesterol depletion effect suggests that Ce-imp-2 acts
upstream of LRP-1 in C. elegans and promotes cholesterol
biosynthesis.
Zebrafish
Analysis of megalin expression during CNS development
has been carried out in rodents and zebrafish (Willnow et al.,1996; McCarthy et al., 2002; Assémat et al., 2005b). In
zebrafish embryos, megalin is prominent in the floor plate of
the neural tube by 16 h post-fertilisation and 8 h later is
expressed in cells of the ventral floor plate and the apical
surfaces of cells lining the neural tube lumen. Later (33 h) it is
detected in cells of the luminal surface of both the forebrain
and midbrain, with strong expression at the midbrain–
hindbrain border. There is no megalin expression in the
notochord (McCarthy et al., 2002).
Mammalian development: peri-implantation
Megalin is expressed in the mammalian embryo long before
development of the foetal shape, let alone specific organs.
Following fertilisation, rounds of cell division result in the
formation of a blastocyst, the endpoint of pre-implantation
development; this comprises the inner cell mass (ICM) and,
surrounding the ICM, the trophectoderm (TE). Cells of the ICM
are predominantly apolar and undifferentiated, whereas the TE
is a functional epithelium with outward-facing apical cell
surfaces. It contributes to blastocoele expansion at the 32-cell
stage (Wiley, 1984), is important for implantation, gives rise to
extra-embryonic tissues but does not contribute to the formation
of embryonic tissues (Rossant, 1986).
Gueth-Hallonet et al. (1994) reported that megalin is first
synthesised in 16-cell stage embryos and is found in coated pits
between the microvilli of TE cells undergoing epithelial
differentiation. Secondary lysosomes form during the 16-cell
stage (Fleming and Pickering, 1985; Fleming et al., 1986). This
led Gueth-Hallonet et al. (1994) to conclude that megalin first
appears during final maturation of the endocytic system.
However, Assémat et al. (2005a) showed that megalin is first
expressed in 8-cell stage embryos when segregation of TE and
ICM is initiated. Cubilin is also expressed in 8-cell stage
embryos and has a very similar expression pattern to megalin in
pre-implantation and early post-implantation embryos; forma-
tion of megalin–cubilin complexes allows uptake of apolipo-
protein A-I (apoA-I) by TE cells in the blastocyst (Assémat et
al., 2005a). Megalin appears in the embryo concurrently with
the development of the endocytic system; it complexes with
cubilin in pre-implantation embryos in order to provide
nutrition to the developing foetus.
Shortly before implantation occurs (5 days post-fertilisation
in mouse), ICM cells differentiate to form the primitive
endoderm (Gardner, 1985), which expresses high levels of
both cubilin and megalin in membrane-coated pits and endo-
somes. This primitive endoderm then differentiates into parietal
and visceral endoderm (VE), which express megalin, cubilin and
AMN (Sahali et al., 1988; Kalantry et al., 2001). AMN and
cubilin form the subunits of the cubam receptor, and both
molecules may be required for endocytosis and/or transcytosis of
ligands in the VE during gastrulation for proper growth of the
embryo (Strope et al., 2004). After implantation, VE differenti-
ates into the visceral yolk sac (VYS), which until the establish-
ment of the allantoic placenta is the only interface between the
foetus and mother. A role for megalin during implantation is
suggested by its restricted expression in primitive endoderm.
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complexes (Willnow et al., 1992), which are produced in vitro by
mouse blastocysts cultured at the time of implantation (Strick-
land et al., 1976; Sappino et al., 1989). Megalin and LRP show
significant homology and bind many of the same ligands,
including PA–PAI complexes (Bu et al., 1992; Christensen et al.,
1992; Kounnas et al., 1992, 1993; Willnow et al., 1992). Both
these LDLR family members are present in pre-implantation
blastocysts, suggesting that both are involved in implantation.
The VYS is crucial for survival and normal growth in
rodents and the endodermal cells of this structure express
megalin, cubilin and amnionless (Sahali et al., 1988; Kalantry
et al., 2001). Despite the appearance of amnionless in the
primitive endoderm after implantation (Kalantry et al., 2001),
cholesterol uptake by VYS early post-implantation appears to
be mediated by megalin/cubilin complexes (Assémat et al.,
2005a). AMN is required for murine gastrulation but is not
essential for human gastrulation (Tanner et al., 2003) and this
probably reflects, at least in part, differing maternal-embryonic
exchange mechanisms. A study by Carney and co-workers
(2004) highlighted the fact that rats, rabbits and humans utilise
fundamentally different strategies for waste/nutrient exchange.
Whereas rodents exclusively rely on the VYS, rabbit embryos
are not completely enclosed by this structure until gestational
day 13, and in humans the chorioallantoic placenta is the
important exchange structure with the VYS possibly fulfilling
a supplemental role (Carney et al., 2004). The varying role of
the VYS possibly also explains why cubilin is apparently not
fundamental to human development.
In summary, megalin is involved in nutrition of the pre-
implantation and the early post-implanted blastocyst, is required
(in conjunction with cubilin and AMN) for the normal growth
and nutrition of the peri-implantation embryo and may have a
role in the implantation process itself.
Kidney
Kidney development in mammals involves the formation of
a pronephros, mesonephros (the functional kidney in fish and
amphibians) and finally the metanephric kidney (comprehen-
sively reviewed in Kuure et al., 2000). The collecting duct
system of the metanephros derives from an initially unbranched
outgrowth of the Wolffian duct, the ureteric bud (UB) (Davies
and Davey, 1999), both of which express megalin (Sahali et al.,
1993; Assémat et al., 2005b). Glial cell line-derived neuro-
trophic factor (GDNF) released by surrounding mesenchyme is
essential for bud initiation and subsequent development (Pichel
et al., 1996; Sainio et al., 1997). It acts upstream of the MAP
kinase pathway (Fisher et al., 2001) and is reliant on HSPGs for
signalling (Barnett et al., 2002).
By E11.5 in mouse, the UB has branched once, and by E12.5
nephrogenesis has begun; later nephrons do not appear until
after birth. Biemesderfer et al. (1992) described four stages of
nephron development on the basis of ultrastructural studies
(Larsson, 1975; Larsson and Maunsbach, 1975). Stage I (renal
vesicle) is characterised by the appearance of the first epithelial
features, including the zona occludens separating the apical andbasolateral domains. However, the glomerular and PT epithelia
do not become distinguishable until stage II (S-shaped body).
By stage III, capillaries invade the forming glomeruli, and
microvilli are detectable on PT cells. PT epithelia and glomeruli
are fully differentiated by the end of stage IV (Biemesderfer et
al., 1992). Kidney formation is an example of morphogenesis
reliant on branching epithelium, resulting in a so-called
‘epithelial tree’. Nephrons found in the centre of this tree are
formed early in development, with newer nephrons at the
periphery of the organ.
During nephrogenesis, Biemesderfer et al. (1992) reported
that megalin is not expressed until stage III of nephrogenesis
and that expression is restricted from the outset to apical
clathrin-coated membrane domains and endosomes. However,
a later study demonstrated megalin expression in S-shaped
bodies during stage II, and in the perinuclear envelope and
cytoplasmic vesicles as well as at the apical surface (Abbate et
al., 1994). By stage III, co-localisation of RAP and
cytoplasmic megalin was evident in the perinuclear envelopes
and RER cisternae of immature PT cells; RAP was not
detected at the cell surface (Abbate et al., 1994). By stage IV,
apical staining in PT appears to be restricted to the coated pit
region of the brush border (Biemesderfer et al., 1992) but it is
heterogeneous; not all the microvilli express megalin (Abbate
et al., 1994). RAP forms a heterodimer with megalin in RER
within 30 min of megalin synthesis (Biemesderfer et al.,
1993). Taken together with the co-localisation data presented
above, this is consistent with the hypothesis that RAP assists
in the folding and assembly of megalin within the ER, and in
trafficking of newly synthesised megalin to the cell surface.
Clathrin distribution appears to be random during early
stages of nephrogenesis but by stage IV it is almost exclusively
expressed in the brush border of the PT, paralleling megalin
expression (Biemesderfer et al., 1992). Exogenous horseradish
peroxidase (HRP) uptake has been used to demonstrate that
nephrons are functional (Rodman et al., 1986). During the
latter stages of nephrogenesis, megalin and HRP were found
to localise in the same PT cells, often in the same endosomes,
and in general HRP was not endocytosed if megalin was
absent (Biemesderfer et al., 1992). As nephrons mature,
megalin becomes progressively concentrated in clathrin-
coated pits on the apical domain of PT cells. This coincides
with vascularisation of the glomerulus and initiation of
glomerular filtration, and therefore the ability of the PT to
reabsorb protein coincides with megalin expression (Biemes-
derfer et al., 1992; Christensen and Verroust, 2002) and the
apical distribution of clathrin at the brush border. This is
consistent with the endocytic role of megalin in the adult
kidney. Although newborn megalin−/− kidney PT cells have
smaller and less apical vesicles compared to wild-type cells,
megalin is not required for kidney development (Willnow et
al., 1996) but it is necessary for proper renal function.
CNS
Megalin may contribute to neurological conditions such as
Alzheimer's disease by virtue of its ability to endocytose the
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al., 1999), suggesting a role in the adult brain. Its importance in
the developing brain was highlighted by the introduction of
megalin knockout (KO) mice (Willnow et al., 1996). Although
they also show pronounced lung and kidney defects, these mice
are mainly characterised by an abnormal head shape. Generally,
newborn megalin−/− mice have a shortened nose, flattened
forehead, often a characteristic protrusion in the midline of the
crown and in some cases small eyes or no eyes at all. The
olfactory bulbs are almost always absent and the forebrain
hemispheres are fused (Willnow et al., 1996).
The expression patterns of megalin and cubilin during CNS
development in the rat have recently been documented
(Assémat et al., 2005b). Early in development (E11), megalin
is detected in the neuroepithelium of the neural tube and the
notochord, but notochordal expression is lost by E13. Both
receptors are detected in ventral regions by E13: in the optic
recesses, the ventral diencephalon, the ventral spinal cord, the
newly formed choroid plexus and also in the primordium of the
pineal gland, the hippocampal ventricular zone and strongly in
the cortical hem (Assémat et al., 2005b). After E15, expression
of both receptors is progressively restricted, becoming limited
to the choroid plexus, the ventricular zone of the ventral lateral
vesicle and cortical hem, spinal cord and ventricular regions of
the third and fourth ventricles (Assémat et al., 2005b).
During normal murine development, megalin expression is
restricted to the apical surface of the neuroepithelium at E9.5,
and in megalin−/− embryos this expression is lost (Willnow et
al., 1996). The apical surface of the neuroepithelium is exposed
to amniotic fluid before neural tube closure, so in wild-type
animals megalin is ideally situated for endocytosis of molecules
from this medium. Failure to endocytose essential nutrients for
growth and development of the neuroepithelia may contribute to
the defects seen in megalin−/− mice. This is akin to the
proposed role of megalin in the peri-implantation embryo
discussed above.
The striking features of the megalin−/− mouse brain are a
markedly reduced telencephalon (TEC) and holoprosencephaly
(HP) (Willnow et al., 1996; Spoelgen et al., 2005), but the
aetiology of this holoprosencephalic syndrome is unclear. One
contributing factor may be disruption of nutrient uptake,
specifically cholesterol-rich lipoproteins, before neural tube
closure. Impaired cholesterol biosynthesis is also likely to play a
part, as is the effect of megalin gene disruption on other
important mediators of CNS development. The brain synthe-
sises cholesterol (Dietschy et al., 1983); preventing cholesterol
synthesis results in HP, which supports the hypothesis that
megalin is required for normal cholesterol transport in the
embryo (Willnow et al., 1996). The drug AY9944 inhibits 7-
dehydrocholesterol-Δ7-reductase, a late enzyme in the choles-
terol biosynthetic pathway; when administered to rats it
produces a holoprosencephalic syndrome similar to that seen
in megalin KO mice (Roux et al., 1979). However, there is also
evidence that disruption of pathways involved in the specifica-
tion of the dorsoventral axis of the rostral neural tube
contributes to HP. Components of these pathways include
BMPs (Golden et al., 1999) and Shh (Chiang et al., 1996).The earliest phenotypic characteristic of megalin−/−
embryos is the reduced size of the TEC (Willnow et al.,
1996), and this is accompanied by a decrease in neuroepithelial
wall thickness, most noticeable in the entopeduncular area
(AEP) (Spoelgen et al., 2005). In wild-type mice, megalin and
Shh are co-expressed in the AEP, but Shh expression is lost by
E10.5 in megalin KOs. It is therefore likely that loss of Shh
signalling in the AEP of mutant mice is responsible for the small
size of the TEC and the loss of ventral cell fate in this structure
(Spoelgen et al., 2005). Concordant with this loss of signalling,
megalin−/− embryos present with impaired establishment of
neuroepithelial progenitors and considerably reduced oligoden-
droglial and interneuronal populations in the ventral forebrain,
as found in mice with perturbed Shh signalling (Fuccillo et al.,
2004). Shh does not function in isolation; unless Fgf 8 and
BMP4 act in synergy with it, proper proencephalic development
does not ensue. These components play key roles in
dorsoventral patterning of the rostral head (Ohkubo et al.,
2002). In E9.5 megalin−/− embryos, BMP4 (a potent antagonist
of Shh signalling) is overexpressed, resulting in enhanced and
ventrally expanded BMP4 signalling in the proencephalon
(Spoelgen et al., 2005). BMP4 binds strongly to megalin and
can be endocytosed by this receptor in BN16 cells, raising the
possibility that megalin is a receptor for BMP4 in the early
forebrain (Spoelgen et al., 2005). It is conceivable that megalin
is a negative regulator of BMP4 in dorsal neuroepithelium, and
that in mutant mice a loss of megalin results in an increase in
dorsal BMP4 signals, suppressing Shh and causing HP and
impairment of ventral cell fates (Spoelgen et al., 2005).
Although the precise details have not yet been elucidated, it is
clear that a lack of megalin results in defects in Shh and BMP4
signalling pathways and in impaired establishment of ventral
cell fates in the developing CNS. Interactions between the Shh
signalling pathway and megalin have been hypothesised,
particularly with regard to the CNS, and possible modes of
interaction are discussed later.
Reproductive tracts
Megalin has important roles during development of
reproductive organs, primarily through its ability to internalise
sex steroids bound to carriers such as sex hormone-binding
globulin (SHBG) and specifically deliver them to target tissues
(Hammes et al., 2005). In adults, expression of cubilin, megalin
and apoJ in the reproductive tract epithelia of both sexes appears
to be required for the functional maturation of spermatozoa,
probably through direct interaction.
Spermatozoa released into seminiferous tubules are func-
tionally immature. To become capable of fertilisation, they must
undergo structural and biochemical changes, including remo-
delling of the plasma membrane to reduce phospholipid content
and alter the cholesterol composition, as they travel through the
efferent ducts, epididymis and vas deferens (reviewed by
Hermo et al., 1994; Cooper, 1998; Jones, 1998). In adult males,
megalin is found in epithelia of the efferent ducts, epididymis
and vas deferens, and it mediates the endocytosis of apoJ
(Andonian and Hermo, 1999; Morales et al., 1996). Cubilin is
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in spermatozoa maturation through plasma membrane interac-
tions and must bind to megalin in order to be endocytosed (Van
Praet et al., 2003).
In addition to these effects on the maturing sperm plasma
membrane, megalin is expressed by epithelia lining the ductal
region and ampulla of the rat seminal vesicle and binds to
seminal vesicle secretory protein II (SVS-II) with high affinity.
It can mediate SVS-II endocytosis leading to lysosomal
degradation, and this is inhibited by RAP (Ranganathan et al.,
1999). After fertilisation, both megalin and cubilin appear to
have roles during blastocyst formation and embryo implantation
and also in providing essential nutrients to the developing foetus
(see above).
Megalin is strongly expressed in the efferent ducts through-
out postnatal development in male rats, but not until postnatal
day 21 is it expressed in any part of the epididymis (Hermo et
al., 1999). Epididymal expression is transient in the distal
segment and the distal caput. Megalin expression is maintained
throughout postnatal development in all other areas of the
epididymis except the proximal initial segment, which does not
express the protein (Hermo et al., 1999). This expression pattern
correlates with apoJ, a secretory product of Sertoli cells
involved in remodelling the spermatozoon plasma membrane
(Law and Griswold, 1994) and therefore probably in the
maturation of spermatozoa.
Notwithstanding the maturation processes within the male
reproductive tract, ejaculated spermatozoa are unable to fertilise
an ovum; capacitation is only acquired after residence in the
female reproductive tract (Chang, 1951; Austin, 1952). Apical
expressions of megalin and cubilin in uterine epithelium and the
oviduct are evident throughout the oestrous cycle, with maximal
expression during the oestrous and metestrous stages; apoJ and
apoA-I are also expressed in these epithelia (Argraves and
Morales, 2004). Uterine glands may synthesise both these
proteins (Argraves and Morales, 2004), which potentially
accept sperm cholesterol as they do during maturation in the
male reproductive tract. Spermatozoa do not express megalin or
cubilin (Morales et al., 1996; Van Praet et al., 2003). They are
therefore reliant on epithelia expressing these receptors so that
ligands such as apoJ and apoA-I, the main constituent of HDL,
can remodel the plasma membrane to establish acrosomal
responsiveness and capacitation. It is likely that maturation of
spermatozoa and fertilisation capacity are coupled processes,
requiring removal of cholesterol from the plasma membrane,
initially in the male reproductive tract and then in the female
(Argraves and Morales, 2004).
Megalin KO mice that survive to adulthood present with
testicular maldescent and vaginal obstruction, phenotypes that
can be induced by anti-oestrogens (Chadwick et al., 1988) and
anti-androgens (Van der Schoot and Elger, 1992). Megalin−/−
females possess a closed vaginal cavity, resulting in gross
inflation of the uterus owing to fluid accumulation (Hammes et
al., 2005); in wild-types, the vaginal cavity opens 4–5 weeks
after birth (Rodriguez et al., 1997). The vaginal tissue of
megalin KO mice is reminiscent of prepubertal tissue of wild-
types (Hammes et al., 2005). Its histological appearance,together with the fact that anti-oestrogens delay vaginal opening
(Chadwick et al., 1988; Ashby et al., 2002), suggests that
defective oestrogen signalling is responsible for this
malformation.
In megalin−/− males, the left testis remains in the body
cavity rather than the scrotum owing to failure of the
inguinoscrotal phase (postnatal) of testes descent. This
cryptorchid testis is very small and poorly developed, with
degenerated germinal epithelium of the seminiferous tubules, an
absence of germ cells, and an epididymis devoid of sperm
(Hammes et al., 2005). In addition, the cranial suspensory
ligament (CSL), one of two tissues controlling the position of
the gonads in both sexes (Zimmermann et al., 1999), was still
present in new-born KO mice, tethering the testes and
epididymides to the abdominal body wall dorsal to the kidney.
Normally, it regresses during development and is absent in
newborns. Nevertheless, the descended testis in male KO mice
appeared to be normal (Hammes et al., 2005). This study
suggests that megalin deficiency impairs spatially and tempora-
rily restricted activities of sex steroids, in line with distinct
expression pattern of the receptor during genital development
(Hammes et al., 2005). Although the right testis of megalin−/−
male mice appear to function normally, it is not clear whether
spermatozoa produced by these mice are capable of fertilisation.
The role of megalin in other organs
During respiratory tract development in rats, cubilin and
megalin are expressed in the epithelium of the tracheal
diverticulum at E11. In subsequent stages of development,
both proteins are found in the bronchial lumen of developing
lung buds and the apical regions of epithelial cells lining the
trachea. By the end of gestation, few bronchi remain positive
(Assémat et al., 2005b). Most megalin−/− mice die perinatally
from respiratory insufficiency. Lungs of newborn KO mice are
characterised by emphysematous and atelectic areas, and it is
thought that impaired pulmonary inflation and alveolar
expansion are the cause of death (Willnow et al., 1996).
Megalin expression has been reported in adult rat type II
pneumocytes (Chatelet et al., 1986; Zheng et al., 1994) and
human type II lung epithelial cells (Lundgren et al., 1997), and
it has been proposed that in adult lung megalin may be
important in supplying vitamin E to such cells (Kolleck et al.,
2002). Immortalised foetal rat alveolar pre-type II cells express
high levels of megalin, which can participate in regulating
proteinase activity (Stefansson et al., 1995). This might be
relevant to lung physiology and pathology; Willnow et al.
(1996) proposed that an imbalance in proteolysis may be
responsible for the lung abnormalities in megalin-deficient
mice. There is supporting evidence from literature concerning
α1-antiproteinase deficiency and quartz-induced emphysema
(Zay et al., 1995), and transgenic mice overexpressing
collagenase (D'Armiento et al., 1992), in which increased
extracellular proteolytic activity causes analogous structural
changes.
Developing sensory organs express megalin and cubilin. In
the adult eye, megalin has been detected in the retina and ciliary
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important, although probably not essential, for normal eye
development. It is expressed in the optic vesicle, which gives
rise to the optic cup, at E11 in rats; but by E18, the only
megalin-expressing areas are the outermost layers of the neural
retina and the presumptive ciliary body. No expression is
evident in the lens vesicle, corneal ectoderm or the perioptic
mesenchyme (Assémat et al., 2005b). The role(s) of megalin in
this organ is unclear but, as noted above, many megalin−/−
newborn mice present with small eyes, or in some cases no eyes
at all (Willnow et al., 1996). Pax-6 is a master control gene for
eye morphogenesis (as reviewed by Gehring, 1999). Gene
disruption is characterised by a small eye phenotype in
heterozygous mice and in humans; homozygous pax-6 mutation
is lethal to murine embryos. Not only do they lack eyes but the
nose is also absent, and they have some brain damage.
In adult rat ear, megalin is expressed in the cochlear duct,
specifically on the apical surfaces of marginal cells of the stria
vascularis, epithelial cells of spiral prominence and Reissner's
membrane (Mizuta et al., 1999). During development, both
cubilin and megalin are expressed in various presumptive
structures. After E14, the sensory epithelia of the vestibular
(utricle, saccule) and cochlear components, as well as the
semicircular ducts, express both molecules; by E18 both are
expressed in vestibular and cochlear hair cells (Assémat et al.,
2005b). Malformations in the ears of megalin KO mice have not
been reported and it is unclear what role(s) megalin fulfils in this
organ. The role of megalin in the nose is also unknown. At E14
in rats, the olfactory epithelium and forming vomeronasal organ
strongly express megalin. However, the basal cells of the
olfactory epithelium, the developing snout and whiskers do not
(Assémat et al., 2005b).
The lumen of the developing foregut expresses megalin and
cubilin, as do some cells of the intestinal tube and epithelial
cells lining the stomach. There is transient expression in the
oesophagus (E14–E17 in rats), and although the dorsal pancreas
shows low levels of megalin expression early in development,
none is apparent by E14 (Assémat et al., 2005b). In adults,
megalin is expressed in the intestinal brush border (Yammani et
al., 2001), and throughout development it is expressed in the
epithelium of the small intestine (Assémat et al., 2005b). It is
thought to complex with cubilin in the gastrointestinal uptake
and transport of vitamin B12 (Yammani et al., 2001), a process
that also requires AMN, most likely in a complex with cubilin
(He et al., 2005). There is also recent evidence to support a role
for megalin in delivering folate to suckling animals. Folate
binds to high affinity folate-binding proteins (FBPs); megalin
has been shown to bind bovine and human milk FBPs and
mediate cellular uptake of FBP in vivo and in vitro (Birn et al.,
2005). Adult human and mouse gallbladder epithelia express
megalin, and it has been proposed that megalin has a role in
gallstone pathogenesis through disruption of cholesterol
adsorption by the gallbladder epithelium (Erranz et al., 2004).
To date, there is no information on the expression or role of
megalin during gallbladder development.
Megalin is present in adult mammary epithelia (Lundgren et
al., 1997) but as yet no role during mammary gland deve-lopment has been reported. It probably has a role in the
developing heart; mesothelial cells of the pericardium express
both megalin and cubilin (Assémat et al., 2005b). It appears that
there is no megalin expression in the developing liver, spleen or
musculoskeletal system (Assémat et al., 2005b).
Megalin expression, transient or otherwise, during organo-
genesis of many structures and systems indicates that it is an
important mediator during development. The perinatal death of
megalin-deficient mice supports this inference.
Interactions with other developmental pathways
Sonic hedgehog (Shh)
There is now in vitro evidence that Shh is included
among the multitude of molecules with which megalin is
known to interact functionally (McCarthy et al., 2002). Shh
is a developmental morphogen with important roles during
CNS formation, development of limb buds, the pulmonary
system, the reproductive tract and the eye as well as other
organs (reviewed in Fisher and Howie, 2005). Work by
Ingham and colleagues (1991) led to the articulation of the
now well-established model of Hedgehog (Hh) signalling in
Drosophila and a parallel Shh pathway in vertebrates. Many
of the detailed interactions have been elucidated, but some
aspects of the pathway remain speculative. In-depth discus-
sions of both the Hh pathway in Drosophila and its
vertebrate counterpart are available (Cohen, 2003; Fisher and
Howie, 2005). Only a general overview will be presented
here.
Biologically active Shh (N-Shh) is formed by autocatalytic
cleavage of the precursor protein, resulting in a 19-kDa ligand
with a covalently linked cholesterol moiety at the C-terminus. It
has been proposed that the addition of cholesterol allows N-Shh
to carry out long-range signalling (Lewis et al., 2001), as does
the molecule Dispatched (Disp). In resting cells, the receptor for
Hh, patched (Ptch), inhibits signalling by the transmembrane
molecule smoothened (smo). This eventually results in cleavage
of the molecule cubitis interruptis (Ci) and the formation of CiR,
a truncated form that acts as a transcriptional repressor,
preventing the transcription of Ci target genes. The mammalian
homologues of Ci are the Gli transcription factors. When Hh
binds to Ptch (possibly with the aid of HSPGs), the inhibition of
smo is repressed, allowing downstream signalling. Cos-2
tethers a group of segment polarity proteins to microtubules,
and full-length Ci is bound to these. Recruitment of cos-2 to
smo causes Ci to dissociate from the cytoskeleton, preventing
its cleavage to CiR. Full-length Ci is translocated to the nucleus,
where it acts as a transcription factor for target genes containing
Ci-binding sites (see Fig. 2).
The importance of Hh/Shh in developing organisms cannot
be overestimated; its roles are many and varied, encompassing
both early and late stages of embryogenesis. Like Shh,
megalin also has roles in early development as evidenced by
its presence in TE cells (Gueth-Hallonet et al., 1994) and the
VYS (Sahali et al., 1988). Its expression during organogen-
esis, particularly of the renal proximal tubule (Christensen and
Fig. 2. Simplified overview of the hedgehog signalling pathway. When Hh binds to Ptch, the inhibition of smo is repressed and full-length Ci can translocate to the
nucleus and activate target genes. When Ptch remains unbound it inhibits signal transduction by smo, and this ultimately results in the formation of Ci75 (CiR), which
represses the transcription of target genes. This diagram provides a basic schematic of the Hedgehog pathway in Drosophila. Mammalian homologue genes are in
parentheses where applicable.
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al., 1996), is well documented.
Megalin–Shh interactions
Many developmental abnormalities in mice that lack
components of the Shh pathway are akin to those found in
megalin−/− mice. The most noticeable abnormalities in
megalin-deficient embryos involve the CNS (Willnow et al.,
1996). Shh−/− and smo−/− mice, as well as mice lacking
dispatched (Disp), which is critical for the secretion/long-range
signalling of N-Shh, display neurodevelopmental abnormal-
ities. This is also the case in smo−/− zebrafish embryos and
partially rescued Ptc−/− embryos (McCarthy and Argraves,
2003). Such striking similarities have led to the suggestion thatmegalin is a regulatory component of the Shh signalling
pathway (Herz and Bock, 2002).
Megalin has been shown to bind Shh in a radiolabelled
ligand-binding assay, by ELISA and surface plasmon
resonance (SPR) measurements (McCarthy et al., 2002). A
recombinant fusion protein of N-Shh with glutathione-S-
transferase (GST-N-Shh) was able to bind megalin with a
dissociation constant (Kd) of 21 nM in the presence of
calcium, and it has also been suggested that Shh and megalin
are co-expressed early in the development of the nervous
system (McCarthy et al., 2002). Interactions among megalin,
RAP and Shh have been investigated. Megalin–Shh com-
plexes are endocytosed by BN cells (rat yolk sac cell line)
(McCarthy et al., 2002), and it has been argued that megalin-
mediated endocytosis leads to lysosomal degradation,
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fragments of ligands in media after in vitro culture
(Stefansson et al., 1995). However, megalin–N-Shh com-
plexes appear resistant to dissociation at pH 4.5; the mechan-
ism(s) by which some ligands bypass lysosomal degradation
is unclear.
The available in vitro data, together with the similarities
found in null mutant embryos, have led to the proposal of
possible models for the role of megalin in the neurodevelop-
mental biology of Shh (McCarthy and Argraves, 2003), which
Cohen (2003) has discussed (inter alia). Three possible
models based on the commentary of McCarthy and Argraves
(2003) are outlined below and discussed in the light of
available evidence. However, it must be stressed at the outset
that it is not yet clear whether megalin constitutes a com-
ponent of the Shh pathway/network, or if it merely binds Shh
and internalises it in the relevant compartments of the target
cell.
The first model proposes that N-Shh signals directly via
megalin (Fig. 3A). As mentioned previously, HSPGs in the
thyroid aid the binding of megalin to its ligands (Lisi et al.,
2003). It may be the case that in cells that co-express Shh and
megalin, possibly during early development of the CNS as
proposed by McCarthy et al. (2002), Shh binds to HSPGs,
which then facilitate binding to megalin, thereby allowing these
proteins to interact, after which signalling ensues. This
suggestion is not implausible and has at least some circum-
stantial support. For instance, HSPGs synthesised by the
enzymatic action of tout velu, an integral membrane protein
of the EXT gene family, regulate Shh movement (Bellaiche et
al., 1998). A very similar model for Shh binding to Ptch on cell
surfaces has been advanced (Cohen, 2003).
A second proposal is that cells internalise Shh by megalin-
mediated endocytosis, a process that is reliant on RAP (Fig.
3B). The observation that Shh can be internalised by megalin-
containing cells during development of the CNS and also by
BN cells (McCarthy et al., 2002) lends credence to this
proposal. Megalin-dependent endocytosis of Shh may be
required to regulate its availability to Ptch, which is one target
of Shh. Alternatively, endocytosis may deliver Shh to
vesicular pools of Ptch (Cohen, 2003), a plausible reason
for its apparent ability to bypass lysosomal degradation.
A third model of Shh–megalin interaction is that Shh
undergoes transcytosis whereas megalin internalises Ptch and
smo (Fig. 3C). Again, this idea is consistent with the apparent
resistance of Shh to lysosomal degradation. There is no
evidence to date that megalin and Ptch can interact
(McCarthy and Argraves, 2003); it may be the case that
megalin requires the aid of HSPGs and/or RAP in order to
internalise Ptch–smo complexes. However, a somewhat more
plausible idea is that Shh acts as a ligand bridge for
internalisation of Ptch and smo. Support for this comes from
the observation that in kidney epithelial cells, Ptch–smo
complexes are internalised after Shh binding (Incardona et al.,
2002). This third model implies that megalin is either a
component of the Shh pathway or that it can interact with
various components thereof.Conclusions: questions and reflection
Megalin has roles in mammalian development that range
from maturation of spermatozoa, through provision of nutrition
to the early embryo around the time of implantation, to
involvement and/or expression during the normal development
of a wide range of organs (lung, kidney, gastrointestinal tract,
endocrine glands, CNS, special sense organs). Before its
involvement in development was suspected, megalin was
best-known as a widely distributed endocytic receptor on apical
membranes of polarised epithelia. Although it associates with a
wide variety of ligands, especially when acting in conjunction
with cubilin, its primary role is in the uptake of lipoprotein
components, notably cholesterol. Primarily, megalin is a device
for moving apolar substrates into or across epithelial cells.
Is this property relevant to its role in development? The
evidence for megalin having a role in sterol uptake in C. elegans
is consistent with this possibility, as is the cholesterol-
transporting function in sperm maturation, CNS development
and possibly the peri-implantation mammalian embryo.
Because N-Shh undergoes a lipophilic modification, having a
cholesterol moiety covalently linked to the C-terminal in order
to interact with its receptor Ptc and for long-range signalling
(Lewis et al., 2001), this role could also be relevant to the
proposed involvement of megalin in the Shh signalling
pathway.
As discussed in the previous section, megalin and Shh
clearly interact. However, there are arguments against megalin
being a component of the Shh signalling pathway. First, megalin
KO mice have very different (and much less dramatic) lung
phenotypes from Shh KOs. Lack of Shh is always an embryonic
lethal phenotype; 98% of megalin-deficient mice die perinatally.
This suggests that either megalin and Shh do not interact during
lung development or such interaction is not essential for
development of the pulmonary system so long as Ptc is present
and functional. The fact that 2% of megalin-deficient mice
survive to adulthood with no obvious sign of respiratory
insufficiency lends credence to the latter view. Second, RAP
KO mice are indistinguishable from wild types though megalin
expression is only about 23% of normal (Birn et al., 2000b).
Therefore, a 4-fold reduction in megalin expression is
compatible with life; this is not true of Shh expression.
In the 98% of megalin KOmice that die perinatally, the lungs
are not inflated and are characterised by thickened alveolar
walls; this is thought to be the cause of death (Willnow et al.,
1996). Megalin is expressed in adult type II cells of rodents and
humans (Chatelet et al., 1986; Zheng et al., 1994; Lundgren et
al., 1997), the principal producers of lung surfactant, suggesting
that what matters for proper lung inflation and surfactant
production at birth is a “megalin pathway”. That is, megalin
must normally endocytose a particular ligand (or must be
internalised by these cells) at an appropriate stage of
development, otherwise insufficient surfactant is produced
and the lungs, though more or less phenotypically normal, are
not fully functional. Clara cells also produce surfactant
components, though not surfactant protein C (SP-C) (Horowitz
et al., 1991), which is important in the spreading of the surface
Fig. 3. Megalin–Shh interactions. (A) Shh is known to bind to megalin with high affinity and this may be aided by interaction with HSPGs. Once bound, the Shh–
megalin complex may result in intracellular signalling via a ‘megalin’ pathway. An alternative hypothesis is that the Shh–megalin complex interacts with Ptch on the
cell surface and then signalling ensues. (B) Shh binds to megalin on the cell surface and undergoes endocytosis, possibly delivering Shh to vesicular pools of Ptch. The
process requires interaction with RAP. (C) Shh undergoes transcytosis whereas megalin internalises Ptch and smo. Shh may act as a ligand bridge for a complex that
includes megalin, Shh, Ptch and smo, and it may be that RAP and/or HSPGs are involved. Ptch and smo are internalised whereas megalin delivers Shh to the
extracellular surface of the cell, and then is recycled back to the cell membrane.
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expressed on Clara cells, then any surfactant produced by
megalin KO mice would presumably lack SP-C. The fact that
2% of such mice survive to adulthood argues that megalin does
not act in isolation in this process.
Analogous “megalin pathways” might also operate in other
organs. For example, although there is considerable evidence
that megalin is involved in the Shh pathway in CNS
development (see above), is it possible that some of the effectsseen in megalin−/− mice are attributable to abolition of a
“megalin pathway” rather than dysfunctional megalin–Shh
interactions? Megalin is not present in neurons in the adult brain
but it plays an important role in transport of ligands across the
blood–brain and blood–cerebrospinal fluid barriers; in parti-
cular, it appears to be the only receptor for ApoJ, ApoE and
ApoJ-ApoE particles, all of which accumulate in the brain in
Alzheimer's disease (AD) (Chun et al., 1999). It would be
interesting to know whether the brain tissue of megalin-
293C.E. Fisher, S.E.M. Howie / Developmental Biology 296 (2006) 279–297deficient mice that survive to adulthood demonstrates accumu-
lation of these particular ligands. If so, this would support the
idea of a “megalin pathway” that is distinct from the Shh
signalling network, at least in the adult brain if not in the
developing CNS.
The point of these speculations is to suggest that megalin
might have a more crucial role in adult, as well as in developing
organs, than is widely suspected at present. Megalin was only
identified a little over two decades ago and its role in
development has been investigated for less than a decade.
Although its expression patterns in most adult and embryonic
tissues have been described, many of megalin's functions and
interactions with other signalling pathways remain to be
elucidated. It is hoped that this insight into megalin and its
roles in development will encourage research into the many
questions that are now open.
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